Telomir Pharmaceuticals, Inc. (TELO) Net income 2022–2025
Telomir Pharmaceuticals, Inc. (TELO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.4MFY2025 · since FY2022: -$854,147 → -$10.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.4M | +37.0% |
| FY2024 | -$16.5M | -26.5% |
| FY2023 | -$13.1M | -1430.4% |
| FY2022 | -$854,147 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TELO financial trends
TELO RevenueTELO Net marginTELO Gross profitTELO Gross marginTELO Operating incomeTELO Operating marginTELO Operating cash flowTELO Free cash flowTELO Capital expendituresTELO Return on equityTELO Stock buybacksTELO Dividends paidTELO Total assetsTELO Total liabilitiesTELO Shareholders’ equityTELO overview →